Tryptophan-Kynurenine Pathway in Health and Disease

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 20 August 2024 | Viewed by 234

Special Issue Editors


E-Mail Website
Guest Editor
Department of Experimental and Clinical Pharmacology, Medical University, Jaczewskiego Street 8b, 20-090 Lublin, Poland
Interests: excitotoxicity; neurodegeneration; glutamate; kynurenines; kynurenic acid

E-Mail Website
Guest Editor
Chair, Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, Poland
Interests: neurodegeneration; tryptophan metabolism; endothelium; psychiatric disorders; glutamate

Special Issue Information

Dear Colleagues,

The biological significance of tryptophan as a source of metabolites other than serotonin has garnered significant attention in recent years. The conversion of tryptophan to biologically active products occurs in various cells of vertebrates and invertebrates, including microbiota. The tryptophan derivatives kynurenines, formed along the “kynurenine pathway”, are known to integrate and modulate a plethora of physiological and pathological processes, including cellular fate, immune response or learning and memory. In consequence, the link between an imbalanced kynurenine pathway and the development of human disorders is now broadly accepted.

The aim of this Special Issue is to present novel data on the role of the tryptophan–kynurenine pathway in the development of human pathologies, with a special emphasis on the brain, cardiovascular and metabolic disorders, and the identification of novel markers and therapeutic approaches.

We encourage colleagues to submit their contributions in the form of original research papers presenting results from a broad range of in vitro and in vivo experiments, as well as from clinical studies. Timely reviews, either systematic or narrative, that present original concepts and are of interest to either broad scientific society or address highly specialized areas, are also welcome. We look forward to receiving your contributions.

Prof. Dr. Tomasz Kocki
Prof. Dr. Ewa M. Urbańska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tryptophan
  • kynurenine pathway
  • kynurenic acid
  • neuropsychiatric disorders
  • metabolic disorders

Published Papers

This special issue is now open for submission.
Back to TopTop